[2][3] Subsequently, she became a Howard Hughes postdoctoral fellow at the laboratories of Professor Barry Honig in Columbia University, New York, where she focused on structure analysis, prediction and modelling for the purpose of understanding the basis of ligand-receptor interactions.

After that, she joined a London-based biotechnology company, Inpharmatica,[4] where she led a team to develop chemogenomics databases and tools to aid target prioritisation and drug discovery.

In this role, she led the creation of The Knowledge Hub, a multidisciplinary, AI-enabled environment for clinical research and therapy stratification.

[citation needed] In 2021 she joined MD Anderson Cancer Center, in Houston, Texas, where she is Director of Therapeutics Data Science, Professor in the Department of Genomic Medicine and founding faculty of MD Anderson’s Institute of Data Science for Oncology (IDSO).

[citation needed] She is a joint applicant for the Wellcome Biomedical Resource award as well as the Director of Informatics and Technologies for the Chemical Probes Portal.